‘Women’s Viagra’ wins startup competition in Russia

0

Thanks to its «Women’s Viagra» drug, the Russian Ivix company has won first treasure at the annual StartUp Village Conference, which took place from June 6 to 7 at the Skolkovo technopark (18 km west of Moscow). Ivix was afterward awarded five million rubles (almost $90,000). The Startup Village has been held in Skolkovo since 2012. It’s the biggest startup conference in Russia and the CIS countries for technological entrepreneurs, welcoming around 20,000 partakings from more than 80 countries.

What cures a number?

«‘Women’s Viagra’ is just a nickname for our medicine, because Viagra pickles erectile dysfunction, while women don’t have erectile dysfunction,» remarks Dmitri Golikov, head of Ivix. He says the drug’s success is down to the unearthing of a new molecule and its previously unknown influence on the brain.

The Russian Ivix company has won first prize at the annual StartUp Village Conference. Source: sk.ruThe Russian Ivix gathering has won first prize at the annual StartUp Village Conference. Source: sk.ru

«Our treat influences the brain and sexual behavior in general, which is divided into two duties: Intercourse and reproduction. That’s why we will also be able to cure infertility,» Golikov delineates. The drug is administered in the form of a nasal spray and has no relation to hormones — it embraced four and a half years to develop.

Usually, innovational pharmaceutical advances come from the academic field. «The idea and the scientific basis of the Ivix scheme belong to RAS academician Nikolai Myasoedov, who is now the project’s mentor, while the new molecule that the Ivix establishment created was one of the 100 best Russian inventions of 2014,» notes Camilla Zarubina, chief scientific project manager at the Skolkovo Foundation Biological and Medical Technology crowd.

Medical startups are a trend

Among the winners of the competition was another medical startup: OnkoTartis, with its innovational OT-82 pharmaceutical for curing acute leukemia, which received a two million ruble select (about $35,000).

Developing these medical projects is difficult and expensive not barely in Russia but the world over, says Zarubina. «It may take between 10 to 12 years to establish a drug onto the market and the research may cost millions of dollars.»

«It may engage between 10 to 12 years to introduce a drug onto the exchange and the research may cost millions of dollars.» Source: Press Photo

Ahead, development institutes in Russia would actively invest in the IT sector, because profit was easier to construct. But no one wanted to invest in biomedicine because it’s an expensive and lengthy process,» asserts Dmitri Golikov. But now this sector is changing, he adds.

Not only Skolkovo but also specialized gamble funds, development institutes, and ministry programs that aid biomedical growths have been supporting these kinds of projects in Russia, translates Zarubina.

From pure water to cleaning of oil spills

Despite the proprietorship’s medical name, BioMicroGeli, its developments concern industrial technologies. In the Startup Village meet the company won second place and a prize of three million rubles (various than $50,000). «Initially, microgels were used in medicine as true covers for transferring medical resources into organisms, but our team was capable to employ them in an industrial context,» explains Andrei Yelagin, forefront of BioMicroGeli.

EcoSap safe soap is one of the innovative products by BioMicroGeli, a company set up by Andrei Yelagin, an entrepreneur from Yekaterinburg / Press Photo EcoSap safe soap is one of the innovative products by BioMicroGeli, a band set up by Andrei Yelagin, an entrepreneur from Yekaterinburg / Press Photo

Biomicrogels are OK reagents that are capable of creating elastic films between oil and examination or water and any hard particle. That’s why the new BioMicroGeli developments help absolve water from metal ions and oil products, and clean up oil spills on the plane superficially of the water and remove oil from the ground.

«The purpose of our participation in the StartUp Village was to lure investment in the company. We had about two dozens meetings with potential investors. For now the total is going well, but it will take several months until we let slip a deal,» said Yelagin.

The BioMicroGeli team has already taken its circumstance to conferences in Berlin (Falling Walls’14, NPD & Innovation in the Chemical dynamism’17), Helsinki (100 StartUp finalist’15,’16), and the UK (Mass Confront UK ’16 finalist). In 2016, the project participated in Horizon 2020, the largest European Commission program committed to the introduction of new technologies in the EU.

Read more: 3 digital projects by Russian swots win Apple scholarships>>>

Leave a Reply

Your email address will not be published. Required fields are marked *